New online tool rates the risk of breast cancer spreading to the brain
Original title: A validated clinical calculator of a brain metastasis risk (BrMR) prediction model in stage I-III breast cancer patients.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
It was built from past patient records and still needs more testing before doctors use it.
The short version
Doctors built a calculator that rates how likely early breast cancer is to spread to the brain.
What was studied. Researchers reviewed records from 40 282 people with stage I to III breast cancer in Texas. They used those records to build an online risk calculator, then tested it on 1644 other patients in Belgium.
What they found. Brain spread happened in 2408 of 40 282 patients in the Texas group. It happened in 35 of 1644 patients in the Belgium group. The tool did a good job of telling higher risk from lower risk in both groups, and traits like HER2 positive cancer, inflammatory breast cancer, and grade III cancer went with higher risk.
What this means, and what it doesn't
What it could mean: A doctor could use a score like this to see if you have a higher chance of brain spread. That might lead to closer checkups, or a chance to join a study.
What it doesn't mean: This does not mean the tool is ready for your care today. It was built by looking back at old patient records, not by following people forward in a new study. The researchers say that kind of test is still needed first. A risk score is not a diagnosis, it is not a treatment, and it is not a promise of a cure.
Source: PubMed, October 8, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.